NASDAQ · ILMN
Illumina, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarThe next earnings date for ILMN has not been announced yet.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $1.36 | $1.37 | $1.35 | 5 |
| Dec 2026 | $1.50 | $1.54 | $1.39 | 5 |
| Mar 2027 | $1.24 | $1.35 | $1.07 | 3 |
| Jun 2027 | $1.51 | $1.55 | $1.44 | 3 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Zacks · Fintel · RTTNews · The Motley Fool- Zacks · Oct 28, 8:15 AM EDTIllumina (ILMN) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance MeasuresEvaluate the expected performance of Illumina (ILMN) for the quarter ended September 2026, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
- Fintel · Oct 23, 12:40 PM EDTIllumina Consensus Price Target Increased by 19.65% to $250.77The average one-year price target for Illumina (NASDAQGS:ILMN) (SWX:ILMN) has been revised to $250.77 / share. This is an increase of 19.65% from the prior estimate of $209.59 dated September 29, 2026. These figures represent aggregate analyst targets compiled from various resear
- Zacks · Oct 22, 9:00 AM EDTIllumina (ILMN) Reports Next Week: Wall Street Expects Earnings GrowthIllumina (ILMN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks · Oct 22, 7:45 AM EDTILMN Q3 Earnings Preview: Strong Clinical Demand May Lift PerformanceIllumina's Q3 results may benefit from strong clinical demand, NovaSeq X adoption, instrument placements and innovations despite persistent weakness in research markets.
- Zacks · Oct 22, 7:40 AM EDTWill HCA Healthcare's Q3 Earnings Benefit From Higher Admissions?HCA's Q3 results could benefit from higher admissions, occupancy and inpatient revenues, but rising costs and fewer outpatient surgeries cloud the outlook.
- Zacks · Oct 21, 8:36 AM EDTCan Higher Admissions Offset Rising Costs in UHS' Q3 Earnings?Universal Health Services' Q3 revenues are expected to rise on higher patient admissions, but surging operating costs and wage pressures could weigh on earnings growth.
- Zacks · Oct 20, 7:55 AM EDTHow to Find Strong Medical Stocks Slated for Positive Earnings SurprisesInvestors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
- Zacks · Oct 16, 11:10 AM EDTWill Illumina (ILMN) Beat Estimates Again in Its Next Earnings Report?Illumina (ILMN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- RTTNews · Oct 15, 4:20 AM EDTIllumina Launches BioInsight Platform For Genomic And Multiomic Research(RTTNews) – Illumina, Inc. (ILMN), a provider of genetic and genomic analysis technologies, has launched the Illumina BioInsight Platform, a unified software environment designed to help researchers generate biological insights from genomic and multiomic data. The platform brin
- RTTNews · Oct 6, 3:37 AM EDTBiotech Stocks At 52-Week Highs – PCVX +31% On Phase 3 Results, INFU, ILMN +7%, CRL+7%, HTFL +5%(RTTNews) – The following biotech stocks reached a 52-week high on October 5, 2026, driven by key catalysts such as encouraging clinical research data.
- The Motley Fool · Sep 30, 1:35 PM EDT3 Reasons to Buy Grail (GRAL) Hand Over Fist in OctoberGrail’s stock recently hit its all-time high.
- BNK Invest · Sep 30, 10:52 AM EDTInvesco S&P 500 Equal Weight ETF Experiences Big OutflowLooking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Invesco S&P 500 Equal Weight ETF (Symbol: RSP) where we have detected an approximate $398.1 million dollar outflow — that's a 0.4% decrease wee
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Illumina, Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.